R
Riley E. Alexander
Researcher at Indiana University
Publications - 27
Citations - 733
Riley E. Alexander is an academic researcher from Indiana University. The author has contributed to research in topics: Adenocarcinoma & Carcinoma. The author has an hindex of 12, co-authored 27 publications receiving 650 citations. Previous affiliations of Riley E. Alexander include Indiana University – Purdue University Indianapolis.
Papers
More filters
Journal ArticleDOI
Molecular pathology of lung cancer: key to personalized medicine.
Liang Cheng,Riley E. Alexander,Gregory T. MacLennan,Oscar W. Cummings,Rodolfo Montironi,Antonio Lopez-Beltran,Antonio Lopez-Beltran,Harvey M. Cramer,Darrell D. Davidson,Shaobo Zhang +9 more
TL;DR: Recent developments involving the specific molecular mechanisms and markers that have been associated with primary and acquired resistance to EGFR-targeted therapy in lung adenocarcinomas are summarized.
Journal ArticleDOI
Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation.
Liang Cheng,Shaobo Zhang,Riley E. Alexander,Gregory T. MacLennan,Kurt B. Hodges,Beth T. Harrison,Antonio Lopez-Beltran,Rodolfo Montironi +7 more
TL;DR: The nomenclature, clinical features, pathology, differential diagnosis, molecular genetics, and histogenesis of sarcomatoid carcinoma are discussed and Sarcomatoids seems to represent the final common pathway of urothelial carcinoma dedifferentiation.
Journal ArticleDOI
p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma.
Riley E. Alexander,Yingchuan Hu,Jennifer B. Kum,Rodolfo Montironi,Antonio Lopez-Beltran,Gregory T. MacLennan,Muhammad T. Idrees,Robert E. Emerson,Thomas M. Ulbright,David G Grignon,John N. Eble,Liang Cheng +11 more
TL;DR: P16 expression should not be used as a surrogate marker for evidence of HVP infection in either squamous cell carcinoma of the urinary bladder or urothelial carcinoma with squamous differentiation as neither HVP DNA nor protein is detectable in these neoplasms.
Journal ArticleDOI
The landscape of EGFR pathways and personalized management of non-small-cell lung cancer.
Liang Cheng,Shaobo Zhang,Riley E. Alexander,Yongxue Yao,Gregory T. MacLennan,Chong-Xian Pan,Jiaoti Huang,Mingsheng Wang,Rodolfo Montironi,Antonio Lopez-Beltran +9 more
TL;DR: Molecular genetic analyses provide new insights into EGFR pathway alterations and demonstrate promise for predicting the clinical outcome of patients with NSCLC, and the role of KRAS and BRAF mutations and ALK rearrangement in lung cancer-targeted therapy is reviewed.
Journal ArticleDOI
The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging
TL;DR: The aim of this study was to document the common morphologic changes and neoplasms found in a large series of adult and pediatric vesical diverticula, and emphasized that pT2 stage should be eliminated to avoid the confusion in staging these neoplasm.